Skip to main content
SpringerLink
Log in

Tetrahydroisoquinoline Alkaloids in Neurodegenerative Disorders - Influence of Drug Treatment

  • Chapter
Basic, Clinical, and Therapeutic Aspects of Alzheimer’s and Parkinson’s Diseases

Part of the book series: Advances in Behavioral Biology ((ABBI,volume 38A))

  • 20 Accesses

Abstract

The presence of various 1,2,3,4-tetrahydroisoquinoline alkaloids in the human brain has been firmly established1–5 and the possible involvement of these alkaloids in the etiology of some neurodegenerative disorders, such as Parkinson’s disease, or in the craving for alcohol has been the object of many investigations and hypotheses.4–8

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. B. Sjöquist, A. Eriksson, B. Winblad, Brain salsolinol levels in alcoholics, Lancet I: 675 (1982).

    Google Scholar 

  2. B. Sjöquist, and C. Ljungquist, Identification and quantification of 1-carboxysalsolinol and salsolinol in biological samples by gas chromatography-mass spectrometry, J. Chromatogr. Biomed. Appl. 343: 1 (1985).

    Article  Google Scholar 

  3. N. Ung-Chhun, B.Y. Cheng, D.A. Pronger, P. Serrano, B. Chavez, R. Fernandez Perez, J. Morales, and M.A. Collins, Alkaloid adducts in human brain: coexistence of 1-carboxylated and noncarboxylated isoquinolines and ß-carbolines in alcoholics and nonalcoholics, Prog. Clin. Biol. Res. 183: 125 (1985).

    PubMed  CAS  Google Scholar 

  4. T. Niwa, N. Takeda, N. Kaneda, Y. Hashizume, and T. Nagatsu, Presence of tetrahydroisoquinoline and 2-methyl-tetrahydroquinoline in parkinsonian and normal human brains, Biochem. Biophys. Res. Commun. 144: 1084 (1987).

    Article  PubMed  CAS  Google Scholar 

  5. S. Ohta, M. Kohno, Y. Makino, O. Tachikawa, and M. Hirobe, Tetrahydroisoquinoline and 1-methyl-tetrahydroisoquinoline are present in the human brain: relation to Parkinson’s disease, Biomed. Res. 8: 453 (1987).

    Google Scholar 

  6. T. L. Perry, K. Jones, S. Hansen, and R.A. Wall, 4-Phenylpyridine and three other analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine lack dopaminergic nigrostriatal neurotoxicity in mice and marmosets, Neurosci. Lett. 75: 65 (1987).

    Article  PubMed  CAS  Google Scholar 

  7. T. Nagatsu, and M. Yoshida, An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions, Neurosci. Lett. 87: 178 (1988).

    Article  PubMed  CAS  Google Scholar 

  8. P. Dostert, M. Strolin Benedetti, and G. Dordain, Dopamine-derived alkaloids in alcoholism, Parkinson’s and Huntington’s diseases, J. Neural Transm. 74: 61 (1988).

    Article  PubMed  CAS  Google Scholar 

  9. K. Suzuki, Y. Mizuno, and M. Yoshida, Inhibition of mitochondrial NADH-ubiquinone oxidoreductase activity and ATP synthesis by tetrahydroisoquinoline, Neurosci. Lett. 86: 105 (1988).

    Article  PubMed  CAS  Google Scholar 

  10. M. Naoi, S. Matsuura, H. Parvez, T. Takahashi, Y. Hirata, M. Minami, and T. Nagatsu, Oxidation of N-methyl-1,2,3,4-tetrahydroisoquinoline into the N-methyl-isoquinolinium ion by monoamine oxidase, J. Neurochem. 52: 653 (1989).

    Article  PubMed  CAS  Google Scholar 

  11. T. Nagatsu, MPTP and its relevance to Parkinson’s disease, Neurochem. Int. 11: 375 (1987).

    Article  PubMed  CAS  Google Scholar 

  12. D. Dougan, D. Wade, P. Mearrick, Effects of L-dopa metabolites at a dopamine receptor suggest a basis for “on-off” effect in Parkinson’s disease, Nature 254: 70 (1975).

    Article  PubMed  CAS  Google Scholar 

  13. R. D. Myers, Isoquinolines, beta-carbolines and alcohol drinking: involvement of opioid and dopaminergic mechanisms, Experientia 45: 436 (1989).

    Article  PubMed  CAS  Google Scholar 

  14. M. Strolin Benedetti, V. Bellotti, E. Pianezzola, E. Moro, P. Carminati, and P. Dostert, Ratio of the R and S enantiomers of salsolinol in food and human urine, J. Neural Transm. 77: 47 (1989).

    Article  Google Scholar 

  15. Y. Makino, S. Ohta, O. Tachikawa, and M. Hirobe, Presence of tetrahydroisoquinoline and 1-methyl-tetrahydroisoquinoline in foods: compounds related to Parkinson’s disease, Life Sci. 43: 373 (1988).

    Article  PubMed  CAS  Google Scholar 

  16. J. H. Robbins, Alkaloid formation by condensation of biogenic amines with acetaldehyde, Clin. Res. 16: 350 (1968).

    Google Scholar 

  17. A. Brossi, Mammalian TIQ’s: products of condensation with aldehydes or pyruvic acids? Prog. Clin. Biol. Res. 90: 123 (1982).

    Google Scholar 

  18. P. Dostert, M. Strolin Benedetti, and M. Dedieu, Ratio of enantiomers of salsolinol in human urine, Pharmacol. Toxicol. 60 [Supply 1: 13 (1987).

    Google Scholar 

  19. G. Dordain, P. Dostert, M. Strolin Benedetti, and V. Rovei, Tetrahydroisoquinoline derivatives and parkinsonism, in: “Monoamine oxidase and disease - Prospects for therapy with reversible inhibitors”, K.F. Tipton, P. Dostert, M. Strolin Benedetti, eds., Academic Press, London, 1984.

    Google Scholar 

  20. P. Dostert, M. Strolin Benedetti, G. Dordain, and D. Verney, Enantiomeric composition of urinary salsolinol in parkinsonian patients after Madopar, J. Neural Transm., in press.

    Google Scholar 

  21. K. J. Reinikainen, L. Paljarvi, T. Halonen, O. Malminen, V-M. Kosma, M. Laakso, and P.J. Riekkinen, Dopaminergic system and monoamine oxidase - B activity in Alzheimer’s disease, Neurobiol. Aging 9: 245 (1988).

    Article  PubMed  CAS  Google Scholar 

  22. P. Dostert, M. Strolin Benedetti. V. Bellotti, G. Dordain, D. Vernay, D. Deffond, Urinary excretion of salsolinol enantiomers and 1,2dehydrosalsolinol in patients with degenerative dementia, in “Alzheimer’s disease - Epidemiology, Neuropathology, Neurochemistry and Clinics”, K. Maurer, P. Riederer, H. Beckmann, eds., Springer-Verlag, Vienna, in press.

    Google Scholar 

  23. M. Strolin Benedetti, P. Dostert, and P. Carminati, Influence of food intake on the enantiomeric composition of urinary salsolinol in man, J. Neural Transm. [GenSec] 78: 43 (1989).

    Article  Google Scholar 

  24. P. Dostert, M. Strolin Benedetti, P. Carminati, G. Dordain, D. Vernay, Urinary excretion of salsolinol and dehydrosalsolinol in alcoholics, Alcohol Alcohol. 24: 371 (1989).

    Google Scholar 

  25. L. Tampier, H.S. Alpers, and V.E. Davis, Influence of catecholaminederived alkaloids and ß-adrenergic blocking agents on stereo-specific binding of 3H-naloxone, Res. Commun. Chem. Pathol. Pharmacol. 17: 731 (1977).

    PubMed  CAS  Google Scholar 

  26. M. G. Hamilton, M. Hirst, K. Blum, Opiate-like activity of salsolinol on the electrically stimulated guinea-pig ileum, Life Sci. 25: 2205 (1979).

    Article  PubMed  CAS  Google Scholar 

  27. R. H. Fertel, J.E. Greenwald, R. Schwartz, L. Wong, and J. Bianchine, Opiate receptor binding and analgesic effects of the tetrahydroisoquinolines salsolinol and tetrahydropapaveroline, Res. Commun. Chem. Pathol. Pharmacol. 27: 3 (1980).

    PubMed  CAS  Google Scholar 

  28. R. A. North, M.A. Collins, J.D. Milner, P.J. Karras, and D.J. Koziol, Tetrahydroisoquinolines do not act on opiate receptors in the guinea-pig ileum, Eur. J. Pharmacol. 71: 489 (1981).

    Article  PubMed  CAS  Google Scholar 

  29. W. C. Koller, Alcoholism in essential tremor, Neurology 33: 1074 (1983).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Farmitalia Carlo Erba, R&D, Erbamont Group, Milan, Italy

    Philippe Dostert & Margherita Strolin Benedetti

  2. Service of Neurology, Hôpital Nord, Clermont-Ferrand, France

    Gérard Dordain

Authors
  1. Philippe Dostert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Margherita Strolin Benedetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gérard Dordain
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Nagoya University School of Medicine, Nagoya, Japan

    Toshiharu Nagatsu

  2. Israel Institute for Biological Research, Ness-Ziona, Israel

    Abraham Fisher

  3. Jichi Medical School, Tochigi, Japan

    Mitsuo Yoshida

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Plenum Press, New York

About this chapter

Cite this chapter

Dostert, P., Benedetti, M.S., Dordain, G. (1990). Tetrahydroisoquinoline Alkaloids in Neurodegenerative Disorders - Influence of Drug Treatment. In: Nagatsu, T., Fisher, A., Yoshida, M. (eds) Basic, Clinical, and Therapeutic Aspects of Alzheimer’s and Parkinson’s Diseases. Advances in Behavioral Biology, vol 38A. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5844-2_48

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-5844-2_48

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-5846-6

  • Online ISBN: 978-1-4684-5844-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation